Objectives

After participating in this educational activity, attendees should be able to:
1. Explain the risk and typical treatment strategy for thrombotic events in patients antiphospholipid syndrome (APS)

2. Identify challenges in monitoring activated partial thromboplastin time (aPTT) in patients with APS.

3. Discuss strategies for monitoring heparin antifactor Xa levels in patients receiving unfractionated heparin and its correlation to aPTT levels.

Faculty

Leah Mangini, PharmD
PGY1 Pharmacy Resident

Pharmacist

Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.